Cargando…

Clinical characterisation and risk stratification of patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy ≥50 years of age

PURPOSE: With the increased use of genetic testing for arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C), this disease is being increasingly recognised among elderly patients. However, elderly ARVD/C patients were underrepresented in prior cohorts. We aimed to describe the phenotypi...

Descripción completa

Detalles Bibliográficos
Autores principales:	van der Pols, M. J., Mast, T. P., Loh, P., van der Heijden, J. F., Cramer, M. J., Hauer, R. N., te Riele, A. S. J. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bohn Stafleu van Loghum 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5120007/ https://www.ncbi.nlm.nih.gov/pubmed/27580740 http://dx.doi.org/10.1007/s12471-016-0886-7

Ejemplares similares

Arrhythmogenic cardiomyopathy: pathogenesis, pro-arrhythmic remodelling, and novel approaches for risk stratification and therapy
por: van der Voorn, Stephanie M, et al.
Publicado: (2020)

The Netherlands Arrhythmogenic Cardiomyopathy Registry: design and status update
por: Bosman, L. P., et al.
Publicado: (2019)

Arrhythmic risk stratification in arrhythmogenic right ventricular cardiomyopathy
por: Gasperetti, Alessio, et al.
Publicado: (2023)

Quantitative Approach to Fragmented QRS in Arrhythmogenic Cardiomyopathy: From Disease towards Asymptomatic Carriers of Pathogenic Variants
por: Roudijk, Rob W., et al.
Publicado: (2020)

Risk stratification and subclinical phenotyping of dilated and/or arrhythmogenic cardiomyopathy mutation-positive relatives: CVON eDETECT consortium
por: Roudijk, R. W., et al.
Publicado: (2021)

Arrhythmogenic cardiomyopathy: diagnosis, genetic background, and risk management
por: Groeneweg, J. A., et al.
Publicado: (2014)

Late evolution of arrhythmogenic cardiomyopathy in patients with initial presentation as idiopathic ventricular fibrillation
por: Blom, Lennart J., et al.
Publicado: (2018)

Identification of sarcomeric variants in probands with a clinical diagnosis of arrhythmogenic right ventricular cardiomyopathy (ARVC)
por: Murray, Brittney, et al.
Publicado: (2018)

Circulating Biomarkers of Fibrosis Formation in Patients with Arrhythmogenic Cardiomyopathy
por: van der Voorn, Stephanie M., et al.
Publicado: (2023)

Prognostic value of strain by feature-tracking cardiac magnetic resonance in arrhythmogenic right ventricular cardiomyopathy
por: Bourfiss, M, et al.
Publicado: (2022)

Exercise has a Disproportionate Role in the Pathogenesis of Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy in Patients Without Desmosomal Mutations
por: Sawant, Abhishek C., et al.
Publicado: (2014)

Pregnancy course and outcomes in women with arrhythmogenic right ventricular cardiomyopathy
por: Hodes, Anke R, et al.
Publicado: (2016)

Arrhythmogenic Right Ventricular Cardiomyopathy in Pediatric Patients: An Important but Underrecognized Clinical Entity
por: te Riele, Anneline S. J. M., et al.
Publicado: (2021)

The phospholamban p.Arg14del founder mutation in Dutch patients with arrhythmogenic cardiomyopathy
por: van der Heijden, J. F., et al.
Publicado: (2013)

Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia
por: Indik, Julia H, et al.
Publicado: (2003)

Arrhythmogenic right ventricular cardiomyopathy/dysplasia
por: Thiene, Gaetano, et al.
Publicado: (2007)

Implantable Cardioverter‐Defibrillator Therapy in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy: Predictors of Appropriate Therapy, Outcomes, and Complications
por: Orgeron, Gabriela M., et al.
Publicado: (2017)

Left ventricular fibro-fatty replacement in arrhythmogenic right ventricular dysplasia/cardiomyopathy: prevalence, patterns, and association with arrhythmias
por: Zghaib, Tarek, et al.
Publicado: (2021)

Diagnosing arrhythmogenic right ventricular cardiomyopathy by 2010 Task Force Criteria: clinical performance and simplified practical implementation
por: Bosman, Laurens P, et al.
Publicado: (2020)

Assessment of inflammation in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia
por: Campian, Maria E., et al.
Publicado: (2010)

Arrhythmogenic right ventricular cardiomyopathy (ARVC): cardiovascular magnetic resonance update
por: te Riele, Anneline SJM, et al.
Publicado: (2014)

Arrhythmogenic Right Ventricular Cardiomyopathy in a Pediatric Patient
por: Roudijk, Rob W., et al.
Publicado: (2020)

Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy
por: Wallace, Ryan, et al.
Publicado: (2021)

Comparing clinical performance of current implantable cardioverter-defibrillator implantation recommendations in arrhythmogenic right ventricular cardiomyopathy
por: Bosman, Laurens P, et al.
Publicado: (2021)

Imaging of programmed cell death in arrhythmogenic right ventricle cardiomyopathy/dysplasia
por: Campian, Maria E., et al.
Publicado: (2011)

Impact of new electrocardiographic criteria in arrhythmogenic cardiomyopathy
por: Hauer, Richard N. W., et al.
Publicado: (2012)

Development of an algorithm for automatic classification of right ventricle deformation patterns in arrhythmogenic right ventricular cardiomyopathy
por: Groen, Marijn H. A., et al.
Publicado: (2020)

The added value of abnormal regional myocardial function for risk prediction in arrhythmogenic right ventricular cardiomyopathy
por: Kirkels, Feddo P, et al.
Publicado: (2023)

Programmed Ventricular Stimulation as an Additional Primary Prevention Risk Stratification Tool in Arrhythmogenic Right Ventricular Cardiomyopathy: A Multinational Study
por: Gasperetti, Alessio, et al.
Publicado: (2022)

Recurrent and founder mutations in the Netherlands—Phospholamban p.Arg14del mutation causes arrhythmogenic cardiomyopathy
por: van der Zwaag, P. A., et al.
Publicado: (2013)

A new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy( )
por: Cadrin-Tourigny, Julia, et al.
Publicado: (2022)

Sudden Cardiac Death Prediction in Arrhythmogenic Right Ventricular Cardiomyopathy: A Multinational Collaboration
por: Cadrin-Tourigny, Julia, et al.
Publicado: (2020)

Treatment of arrhythmogenic right ventricular cardiomyopathy/dysplasia: an international task force consensus statement
por: Corrado, Domenico, et al.
Publicado: (2015)

Treatment of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: An International Task Force Consensus Statement
por: Corrado, Domenico, et al.
Publicado: (2015)

Safety and Utility of Cardiopulmonary Exercise Testing in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia
por: Scheel, Paul J., et al.
Publicado: (2020)

Feature tracking CMR reveals abnormal strain in preclinical arrhythmogenic right ventricular dysplasia/ cardiomyopathy: a multisoftware feasibility and clinical implementation study
por: Bourfiss, Mimount, et al.
Publicado: (2017)

Electrocardiographic Patterns of Ventricular Arrhythmias in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy
por: Hoffmayer, Kurt S., et al.
Publicado: (2012)

An overlap of Brugada syndrome and arrhythmogenic right ventricular cardiomyopathy/dysplasia
por: Kataoka, Shohei, et al.
Publicado: (2016)

Physical Exercise and Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: An Overview
por: Kaddoura, Rasha, et al.
Publicado: (2022)

Electrocardiographic features of disease progression in arrhythmogenic right ventricular cardiomyopathy/dysplasia
por: Saguner, Ardan M, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_fqdhp2760k95veg0nqghcenobu